Health
Targeted drug found effective in patients who have lung cancer with certain mutations – Medical Xpress
A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial. The trial, which is published in the New Eng…
A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial. The trial, which is published in the New England Journal of Medicine, was conducted by an international team led by investigators at Massachusetts General Hospital (MGH).
A protein called MET affects a wide range of processes within cells, and alterations that activate the MET gene, …
-
General19 hours agoSikh Lane a WA first as Dongara puts multicultural history on the map
-
General22 hours ago‘Prepare to leave’, residents told, after fire crews lose control of planned burn in central Victoria
-
General14 hours agoUS exempts smartphones, computers and other electronics from Donald Trump’s reciprocal tariffs
-
General21 hours agoAlbo isn’t winning, but the Coalition is losing